SEC Form 4 · accession 0001209191-17-037253
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael T Wijas
Officer — VP of Sales, The Americas
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | M | 2,346 | $12.76 | A | 3,584 | D | |
| Common Stock | Jun 1, 2017 | S | 2,346 | $31.4223 | D | 1,238 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $12.76 | Jun 1, 2017 | M | 2,346 | D | Oct 22, 2015 | Oct 22, 2022 | Common Stock | 2,346 | 9,384 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.